Molecular Imaging of Mesenchymal Stem Cell: Mechanistic Insight Into Cardiac Repair After Experimental Myocardial Infarction
暂无分享,去创建一个
[1] Phillip C. Yang,et al. Mesenchymal Stem Cell Therapy for Cardiac Repair , 2014, Current Treatment Options in Cardiovascular Medicine.
[2] Richard T. Lee,et al. Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair. , 2011, Cell stem cell.
[3] Jakub Tolar,et al. Concise Review: Hitting the Right Spot with Mesenchymal Stromal Cells , 2010, Stem cells.
[4] L. Bidaut,et al. Human CD34+ Cells in Experimental Myocardial Infarction: Long-Term Survival, Sustained Functional Improvement, and Mechanism of Action , 2010, Circulation research.
[5] Stefanie Dimmeler,et al. Mechanism of Improved Cardiac Function After Bone Marrow Mononuclear Cell Therapy: Role of Cardiovascular Lineage Commitment , 2010, Circulation.
[6] Jianyi(Jay) Zhang,et al. Long-term functional improvement and gene expression changes after bone marrow-derived multipotent progenitor cell transplantation in myocardial infarction. , 2010, American journal of physiology. Heart and circulatory physiology.
[7] H. Drexler,et al. Cell therapy for the treatment of coronary heart disease: a critical appraisal , 2010, Nature Reviews Cardiology.
[8] G. Belcaro,et al. Kidney function in metabolic syndrome may be improved with Pycnogenol®. , 2010, Panminerva medica.
[9] G. I. Gallicano,et al. Mesenchymal stem cell therapy for treatment of cardiovascular disease: helping people sooner or later. , 2010, Stem cells and development.
[10] S. Janssens. Stem cells in the treatment of heart disease. , 2010, Annual review of medicine.
[11] C. Thiemermann,et al. Mesenchymal Stromal Cells: Current Understanding and Clinical Status , 2009, Stem cells.
[12] M. Andreeff,et al. Direct Evidence of Mesenchymal Stem Cell Tropism for Tumor and Wounding Microenvironments Using In Vivo Bioluminescent Imaging , 2009, Stem cells.
[13] N. Maulik,et al. Mesenchymal stem cell: present challenges and prospective cellular cardiomyoplasty approaches for myocardial regeneration. , 2009, Antioxidants & redox signaling.
[14] Timothy O'Brien,et al. Bone marrow-derived mesenchymal stem cells promote angiogenic processes in a time- and dose-dependent manner in vitro. , 2009, Tissue engineering. Part A.
[15] B. Dawn,et al. Bone marrow-derived mesenchymal stems cells and cardiac repair. , 2009, Minerva cardioangiologica.
[16] V. Nurcombe,et al. Wnt signaling controls the fate of mesenchymal stem cells. , 2009, Gene.
[17] Ahmad Y. Sheikh,et al. Comparison of Transplantation of Adipose Tissue- and Bone Marrow-Derived Mesenchymal Stem Cells in the Infarcted Heart , 2009, Transplantation.
[18] Meijing Wang,et al. VEGF is critical for stem cell-mediated cardioprotection and a crucial paracrine factor for defining the age threshold in adult and neonatal stem cell function. , 2008, American journal of physiology. Heart and circulatory physiology.
[19] M. Gnecchi,et al. Paracrine Mechanisms in Adult Stem Cell Signaling and Therapy , 2008, Circulation research.
[20] M. Eijken,et al. Donor‐Derived Mesenchymal Stem Cells Remain Present and Functional in the Transplanted Human Heart , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[21] P. Hwu,et al. Visualizing fewer than 10 mouse T cells with an enhanced firefly luciferase in immunocompetent mouse models of cancer , 2008, Proceedings of the National Academy of Sciences.
[22] S. Gronthos,et al. Concise Review: Mesenchymal Stromal Cells: Potential for Cardiovascular Repair , 2008, Stem cells.
[23] H. Northoff,et al. Cardioprotection and cardiac regeneration by mesenchymal stem cells. , 2008, Panminerva medica.
[24] Ralph Weissleder,et al. A secreted luciferase for ex vivo monitoring of in vivo processes , 2008, Nature Methods.
[25] Robert Passier,et al. Monitoring of cell therapy and assessment of cardiac function using magnetic resonance imaging in a mouse model of myocardial infarction , 2007, Nature Protocols.
[26] S. Kitamura,et al. Mesenchymal stem cells attenuate cardiac fibroblast proliferation and collagen synthesis through paracrine actions , 2007, FEBS letters.
[27] Xueli Yuan,et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis , 2007, Nature Medicine.
[28] Timothy J Gardner,et al. Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance. , 2007, American journal of physiology. Heart and circulatory physiology.
[29] R. Schwinger,et al. Mesenchymal stem cells induce endothelial activation via paracine mechanisms. , 2007, Endothelium : journal of endothelial cell research.
[30] Joshua M Hare,et al. Multimodality noninvasive imaging demonstrates in vivo cardiac regeneration after mesenchymal stem cell therapy. , 2006, Journal of the American College of Cardiology.
[31] J. Ingwall,et al. Evidence supporting paracrine hypothesis for Akt‐modified mesenchymal stem cell‐mediated cardiac protection and functional improvement , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[32] Hidezo Mori,et al. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction , 2006, Nature Medicine.
[33] R. Hurren,et al. NKG2D splice variants: a reexamination of adaptor molecule associations , 2006, Immunogenetics.
[34] R. Kloner,et al. Allogeneic Mesenchymal Stem Cell Transplantation in Postinfarcted Rat Myocardium: Short- and Long-Term Effects , 2005, Circulation.
[35] M. Gnecchi,et al. Therapeutic potential of endothelial progenitor cells in cardiovascular diseases. , 2005, Hypertension.
[36] W. Vaughn,et al. Mesenchymal Stem Cells Differentiate into an Endothelial Phenotype, Enhance Vascular Density, and Improve Heart Function in a Canine Chronic Ischemia Model , 2005, Circulation.
[37] M. Burnett,et al. Marrow-Derived Stromal Cells Express Genes Encoding a Broad Spectrum of Arteriogenic Cytokines and Promote In Vitro and In Vivo Arteriogenesis Through Paracrine Mechanisms , 2004, Circulation research.
[38] James T. Willerson,et al. Transdifferentiation of Human Peripheral Blood CD34+-Enriched Cell Population Into Cardiomyocytes, Endothelial Cells, and Smooth Muscle Cells In Vivo , 2003, Circulation.
[39] J. Kantelip,et al. Mesenchymal Progenitor Cells Differentiate into an Endothelial Phenotype, Enhance Vascular Density, and Improve Heart Function in a Rat Cellular Cardiomyoplasty Model , 2003, Circulation.
[40] George E Taffet,et al. Myocardial infarction and remodeling in mice: effect of reperfusion. , 1999, American journal of physiology. Heart and circulatory physiology.
[41] Thomas N. Sato,et al. Tie-1 and tie-2 define another class of putative receptor tyrosine kinase genes expressed in early embryonic vascular system. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[42] P. Doevendans,et al. Mesenchymal stromal cells to treat cardiovascular disease: strategies to improve survival and therapeutic results. , 2010, Panminerva medica.
[43] J. George. Stem cell therapy in acute myocardial infarction: a review of clinical trials. , 2010, Translational research : the journal of laboratory and clinical medicine.
[44] Paul D. Kessler,et al. Human Mesenchymal Stem Cells Differentiate to a Cardiomyocyte Phenotype in the Adult Murine Heart , 2002, Circulation.